Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 4 Feb 21 424B4 Prospectus supplement with pricing info
- 4 Feb 21 EFFECT Notice of effectiveness
-
1 Feb 21 S-1/A IPO registration (amended)
- 15 Jan 21 S-1 IPO registration
SNSE similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Registration Statement No. 333-252138 on Form S-1 of our report dated November 12, 2020 (February 1, 2021 as to the effects of the reverse stock split discussed in Note 15) relating to the financial statements of Sensei Biotherapeutics, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Baltimore, Maryland
February 1, 2021